Related Experiment Video
Updated: May 9, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.2K
Comprehensive pharmacy-based investigational drug service: A 40-year update
Helen Karpov1, Kevin Zinchuk1, Jon Silverman1
1Investigational Drug Services, Brigham and Women's Hospital, Boston, MA, USA.
Summary
Pharmacy-based investigational drug services (IDS) have evolved significantly over 40 years. Technological and regulatory advancements have enhanced efficiency, safety, and capacity for managing complex clinical trials.
Area of Science:
- Pharmacy Practice
- Clinical Research Management
- Drug Development
Background:
- The field of pharmacy-based investigational drug services (IDS) has undergone substantial transformation.
- A 40-year review highlights key developments in IDS at a major teaching hospital.
Purpose of the Study:
- To review the evolution of pharmacy-based investigational drug services (IDS) over four decades.
- To reflect on significant advances driven by technology and regulatory changes.
Main Methods:
- Historical review of services and developments within an institutional IDS.
- Analysis of shifts from paper-based to electronic and automated systems.
- Examination of adaptations to new regulatory standards and expanding research scope.
Main Results:
- Transition from paper records to electronic systems like Investigation Drug Service Information System (IDSIS), electronic health records, and automated temperature monitoring.
- Implementation of barcode scanning and automated pharmacy carousel systems.
- Adaptation to new regulations for hazardous medication handling and compounding, supporting complex therapies like gene and cell therapies.
Conclusions:
- The institutional IDS has evolved significantly, mirroring broader trends in research pharmacy.
- Technological integration and regulatory compliance have improved efficiency and safety in managing investigational agents.
- The expanded capacity and role of IDS are crucial for advancing clinical trials and research.
Keywords:
clinical trialsinstitutional pharmacyinvestigational drug servicespharmacy regulatory complianceresearch pharmacytechnology advancementMore Related Videos
Related Concept Videos
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Drug Administration and Therapy Phases: Overview
377
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
377
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Pharmacovigilance
735
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
735
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K

